D
Caris Life Sciences, Inc. CAI
$27.24 $1.134.33% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 09/30/2024
Total Cash And Short-Term Investments 4.76% 2,057.55% --
Total Receivables -47.54% -36.53% --
Inventory 21.40% 11.11% --
Prepaid Expenses 12.56% 39.01% --
Finance Division Loans and Leases Current -- -- --
Total Finance Division Other Current Assets -- -- --
Other Current Assets 0.89% -55.67% --
Total Current Assets 2.51% 386.66% --

Total Current Assets 2.51% 386.66% --
Net Property, Plant & Equipment 4.37% -0.55% --
Long-term Investments 0.00% 0.00% --
Goodwill 0.00% 0.00% --
Total Other Intangibles -- -- --
Finance Div Loans & Leases LT -- -- --
Total Finance Div Other LT Assets -- -- --
Total Other Assets 14.37% 4.38% --
Total Assets 3.09% 227.54% --

Total Accounts Payable 0.94% 18.58% --
Total Accrued Expenses -2.26% -24.51% --
Short-term Debt -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- --
Finance Division Debt Current -10.45% -88.83% --
Total Finance Division Other Current Liabilities -47.73% -30.32% --
Total Other Current Liabilities -47.73% -30.32% --
Total Current Liabilities -4.60% -44.52% --

Total Current Liabilities -4.60% -44.52% --
Long-Term Debt 0.72% 17.99% --
Short-term Debt -- -- --
Capital Leases 15.39% 2.47% --
Finance Division Debt Non Current -- -- --
Total Finance Division Other Non Current Liabilities -- -- --
Total Other Liabilities -86.05% -99.71% --
Total Liabilities 0.81% -22.19% --

Common Stock & APIC 0.03% 2,154,500.00% --
Retained Earnings 0.92% -2.77% --
Treasury Stock & Other 0.49% 2.54% --
Total Common Equity 5.62% 117.42% --

Preferred Stock Redeemable -- -- --
Preferred Stock Non Redeemable -- -- --
Preferred Stock Convertible -- -- --
Preferred Stock, Others -- -- --
Total Preferred Equity -- -- --

Total Common Equity 5.62% 117.42% --
Total Preferred Equity -- -- --
Total Minority Interest -- -- --
Total Equity 5.62% 228.03% --